[Nanotechnology in medicine]
Cuadros-Celorrio M, Llanos-Mendez A, Villegas-Portero R
Record ID 32011000507
Spanish
Authors' recommendations:
We asked for current use and future applications of nanomedicine and there was a blank space in order to freely express opinions or to propose issues considered of interest by experts. 58 questionnaires were sent and 10 responses were obtained (17%). Most experts (60%) knew applications currently used in clinical practice which shows a homogeneity on this question. Likewise, we obtained very similar responses about short-term uses: 80% knew nanodevices to be used in a 5 years horizon, and 7 experts pointed at specific systems and at diseases it will be used on. The bibliometric study stated an exponential growth in the number of papers on nanomedicine in humans, although most of them were review articles. We appreciated concordance between experts’ answers and bibliometric study for technologies to be used in a medium term. Among them, drug releasing systems were emphasized and especially those used for cancer therapy and biosensors as diagnostic tools.
Details
Project Status:
Completed
URL for project:
https://www.aetsa.org/publicacion/nanotecnologia-en-medicina-informe-de-sintesis-de-tecnologia-emergente/
Year Published:
2010
URL for published report:
https://www.aetsa.org/download/publicaciones/antiguas/AETSA_2007-02_F2_Nanomedicina.pdf
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Spain
MeSH Terms
- Humans
- Nanomedicine
Contact
Organisation Name:
Andalusian Health Technology Assessment Area
Contact Address:
Area de Evaluacion de Tecnologias Sanitarias Sanitarias de Andalucia (AETSA) Avda. Innovación, s/n Edificio Arena 1. Sevilla (Spain) Tel. +34 955 006 309
Contact Name:
aetsa.csalud@juntadeandalucia.es
Contact Email:
aetsa.csalud@juntadeandalucia.es
Copyright:
Andalusian Agency for Health Technology Assessment (AETSA)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.